A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
INCB 81776-101
Phase 1 other active
Quick answer
A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies for Advanced malignancies. is a Phase 1 program (other) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Advanced malignancies.
- Phase
- Phase 1
- Modality
- other
- Status
- active